Linked Life Data

15154653

Source:http://linkedlifedata.com/resource/pubmed/id/15154653

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2C
pubmed:dateCreated
2004-5-24
pubmed:abstractText
Taxanes have been widely used against advanced non-small cell lung cancer (NSCLC), alone and in combination with platinum agents. In order to develop a tolerable palliative regimen, we combined carboplatin with low dose docetaxel.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1239-42
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: a phase II study.
pubmed:affiliation
University of Tennessee Cancer Institute, 1331 Union Avenue-Suite 800, Memphis, TN 38104, USA. mjahanze@utmem.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II